Sample Report

Proteomics Tools Report: Research & Clinical Markets, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global proteomics tools market from 2025 to 2030. These tools are fundamental to life sciences, enabling the analysis of proteins, the functional endpoints of biological pathways. The landscape is highly dynamic, with a clear duality: established, first-generation tools (e.g., IHC, ELISAs, Western blot) remain critical in clinical trials and routine diagnostics, while a high-growth research segment is driven by innovative technologies like high-plex affinity platforms and spatial proteomics. The vendor landscape includes large corporations such as Thermo Fisher Scientific and Roche, as well as specialized innovators like Olink, SomaLogic, and Quantum-Si. 

See more details below.

 

 

Complete this form to receive a copy of the sample report.

Segmentations Covered in Market Analysis:

Technology/Tool Type:
  • Standard Immunoassays (ELISA, Western Blot) 
  • Conventional IHC/IF 
  • Mass Spectrometry 
  • Capillary Electrophoresis 
  • Protein Microarrays 
  • Spatial & Imaging Proteomics 
  • High Plex Affinity Assays 
  • Protein Sequencing 
Product Type:
  • Instruments 
  • Reagents 
Customer Type:
  • Academia 
  • Biopharma 
  • CRO 
  • Clinical
Application/Use Case:
  • Basic / Functional Research & Discovery 
  • Preclinical Research 
  • Translational / Clinical Research 
  • Clinical Diagnostics 

 

Product Designation:
  • Research Use Only (RUO) 
  • In-Vitro Diagnostic (IVD) 
Plex Level:
  • 1-2 Plex 
  • 3-19 Plex 
  • 20-99 Plex 
  • 100+ Plex 
Geography:
  • United States 
  • Europe 
  • Asia Pacific (APAC) 
  • Rest of World (ROW)